BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.370
+0.050 (3.79%)
May 27, 2026, 4:59 PM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 680.77 million as of May 27, 2026. Its market cap has decreased by -5.83% in one year.
Market Cap
680.77M
Enterprise Value
633.40M
Revenue
40.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.37
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 680.77M, an increase of 804.34%. That is a compound annual growth rate of 10.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 653.54M | 29.42% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.28T |
| Genmab | 105.81B |
| Coloplast | 90.88B |
| ALK-Abelló | 58.27B |
| Embla Medical | 11.50B |
| ChemoMetec | 5.85B |
| Gubra | 5.55B |
| ViroGates | 101.17M |